内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2020 FISPGHAN意见书：儿童时期肥胖的预防

2020-03-20 国际儿童胃肠病学、肝病学和营养学会联盟 J Pediatr Gastroenterol Nutr. 2020 Mar 20.

肥胖儿童

2020年3月，国际儿童胃肠病学、肝病学和营养学会联盟(FISPGHAN)发布了儿童时期肥胖的预防意见书，全球范围内儿童肥胖症在40年中增长了8倍多，给个人、社会和经济带来巨大负担。本文的主要强调了儿

中文标题：

2020 FISPGHAN意见书：儿童时期肥胖的预防

英文标题：

Prevention of Childhood Obesity. A Position Paper of the global Federation of International Societies of International Societies of Pediatric Gastroenterology, Hepatology and Nutrition (FISPGHAN)

发布机构：

国际儿童胃肠病学、肝病学和营养学会联盟

发布日期：

2020-03-20

简要介绍：

2020年3月，国际儿童胃肠病学、肝病学和营养学会联盟(FISPGHAN)发布了儿童时期肥胖的预防意见书，全球范围内儿童肥胖症在40年中增长了8倍多，给个人、社会和经济带来巨大负担。本文的主要强调了儿童时期肥胖预防的合适的时机和优先级。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=eeaca1c001886669, title=2020 FISPGHAN意见书：儿童时期肥胖的预防, enTitle=Prevention of Childhood Obesity. A Position Paper of the global Federation of International Societies of International Societies of Pediatric Gastroenterology, Hepatology and Nutrition (FISPGHAN), guiderFrom=J Pediatr Gastroenterol Nutr. 2020 Mar 20., authorId=0, author=, summary=2020年3月，国际儿童胃肠病学、肝病学和营养学会联盟(FISPGHAN)发布了儿童时期肥胖的预防意见书，全球范围内儿童肥胖症在40年中增长了8倍多，给个人、社会和经济带来巨大负担。本文的主要强调了儿, cover=https://img.medsci.cn/202043/1585912861372_2020535.jpg, journalId=0, articlesId=null, associationId=1721, associationName=国际儿童胃肠病学、肝病学和营养学会联盟, associationIntro=, copyright=0, guiderPublishedTime=Fri Mar 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年3月，国际儿童胃肠病学、肝病学和营养学会联盟(FISPGHAN)发布了儿童时期肥胖的预防意见书，全球范围内儿童肥胖症在40年中增长了8倍多，给个人、社会和经济带来巨大负担。本文的主要强调了儿童时期肥胖预防的合适的时机和优先级。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=332, tagName=肥胖), TagDto(tagId=1138, tagName=儿童)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=332, guiderKeyword=肥胖, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2472, appHits=151, showAppHits=25, pcHits=664, showPcHits=2367, likes=5, shares=9, comments=11, approvalStatus=1, publishedTime=Fri Apr 03 20:02:30 CST 2020, publishedTimeString=2020-03-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Apr 03 19:21:16 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:07:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击：
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1071088, encodeId=c0de10e108821, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41265183741, createdName=14700eefm31暂无昵称, createdTime=Wed Nov 17 13:53:53 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062107, encodeId=191f106210ec5, content=我觉得很好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Tue Oct 19 22:49:59 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011156, encodeId=c6b8101115605, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4af2491137, createdName=Frinture5624, createdTime=Tue Aug 24 22:54:11 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008974, encodeId=bfb110089e45d, content=希望能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/8e174b74e8a54bf083bdf10586176324/3f60dfcd56e9463fa2797d9b675ae285.jpg, createdBy=b3275485843, createdName=ms倩, createdTime=Wed Aug 18 10:27:27 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954502, encodeId=2f47954502c8, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:10:59 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-11-17 14700eefm31暂无昵称

    积分不够

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1071088, encodeId=c0de10e108821, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41265183741, createdName=14700eefm31暂无昵称, createdTime=Wed Nov 17 13:53:53 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062107, encodeId=191f106210ec5, content=我觉得很好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Tue Oct 19 22:49:59 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011156, encodeId=c6b8101115605, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4af2491137, createdName=Frinture5624, createdTime=Tue Aug 24 22:54:11 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008974, encodeId=bfb110089e45d, content=希望能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/8e174b74e8a54bf083bdf10586176324/3f60dfcd56e9463fa2797d9b675ae285.jpg, createdBy=b3275485843, createdName=ms倩, createdTime=Wed Aug 18 10:27:27 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954502, encodeId=2f47954502c8, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:10:59 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-10-19 419040982

    我觉得很好！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1071088, encodeId=c0de10e108821, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41265183741, createdName=14700eefm31暂无昵称, createdTime=Wed Nov 17 13:53:53 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062107, encodeId=191f106210ec5, content=我觉得很好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Tue Oct 19 22:49:59 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011156, encodeId=c6b8101115605, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4af2491137, createdName=Frinture5624, createdTime=Tue Aug 24 22:54:11 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008974, encodeId=bfb110089e45d, content=希望能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/8e174b74e8a54bf083bdf10586176324/3f60dfcd56e9463fa2797d9b675ae285.jpg, createdBy=b3275485843, createdName=ms倩, createdTime=Wed Aug 18 10:27:27 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954502, encodeId=2f47954502c8, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:10:59 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-08-24 Frinture5624

    积分不够

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1071088, encodeId=c0de10e108821, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41265183741, createdName=14700eefm31暂无昵称, createdTime=Wed Nov 17 13:53:53 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062107, encodeId=191f106210ec5, content=我觉得很好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Tue Oct 19 22:49:59 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011156, encodeId=c6b8101115605, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4af2491137, createdName=Frinture5624, createdTime=Tue Aug 24 22:54:11 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008974, encodeId=bfb110089e45d, content=希望能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/8e174b74e8a54bf083bdf10586176324/3f60dfcd56e9463fa2797d9b675ae285.jpg, createdBy=b3275485843, createdName=ms倩, createdTime=Wed Aug 18 10:27:27 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954502, encodeId=2f47954502c8, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:10:59 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-08-18 ms倩

    希望能下载

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1071088, encodeId=c0de10e108821, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41265183741, createdName=14700eefm31暂无昵称, createdTime=Wed Nov 17 13:53:53 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062107, encodeId=191f106210ec5, content=我觉得很好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Tue Oct 19 22:49:59 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011156, encodeId=c6b8101115605, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4af2491137, createdName=Frinture5624, createdTime=Tue Aug 24 22:54:11 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008974, encodeId=bfb110089e45d, content=希望能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/8e174b74e8a54bf083bdf10586176324/3f60dfcd56e9463fa2797d9b675ae285.jpg, createdBy=b3275485843, createdName=ms倩, createdTime=Wed Aug 18 10:27:27 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954502, encodeId=2f47954502c8, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:10:59 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-07 湘雅科教

    受益匪浅！好文章。

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2020 ESE临床实践指南：肥胖的内分泌检查

欧洲内分泌学会(ESE,European Society of Endocrinology) · 2020-01-10

2016 ISTH指南：使用直接口服抗凝剂治疗肥胖患者

国际血栓与止血学会(ISTH,International Society on Thrombosis and Haemostasis) · 2016-04-27

2019 HFSA共识声明：心衰患者的营养，肥胖和恶病质

美国心衰学会(HFSA,HEART FAILURE SOCIETY OF AMERICA) · 2019-03-12

2016年中国超重/肥胖医学营养治疗专家共识解读

暂未更新 · 2017-05-30

儿童肥胖筛查和治疗的承诺和机会：USPSTF建议声明 2017

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2017-06-24

2017 USPSTF建议声明：儿童和青少年肥胖筛查

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2017-06-20

拓展阅读

2011 IDF 减重手术治疗肥胖伴2型糖尿病的立场声明

国际糖尿病联盟(IDF,International Diabetes Federation) · 2011-03-03

2011CES 中国成人肥胖症防治专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2011-09-01

2012AHA关于父母行为改变策略与代沟研究证据的科学声明：父母和成人监护人作为&ldquo;变更代理人&rdquo;治疗儿童肥胖症的效果评估

美国心脏协会(AHA,American Heart Association) · 2012-01-23

ASCO指南：肥胖癌症患者合适的化疗剂量

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2012-04-02

2012EASO/ESH 肥胖和难治性动脉高血压联合声明

欧洲肥胖症研究学会(EASO,European Association for the Study of Obesity) · 2012-06-05

2012 EASO指南：老年人肥胖的患病率、病理生理、健康后果和治疗选择

欧洲肥胖症研究学会(EASO,European Association for the Study of Obesity) · 2012-06-20